Go offline with the Player FM app!
Ep. 62: “T Cells in Solid Tumors” Featuring Dr. Kristin Anderson
Fetch error
Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on October 30, 2024 01:18 ()
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 376802635 series 2895470
Guest:
Dr. Kristin Anderson is an Assistant Professor at the University of Virginia, where her lab focuses on engineering T cells to overcome immune suppression in the tumor microenvironment. She talks about how her cancer diagnosis changed her career focus, strategies for targeting ovarian cancer, and her transition from postdoc to professor.
Featured Products and Resources:
- Register now for IUIS 2023!
- Support the culture of human T cells and enhance your cell therapy development by using high-performance, cGMP-manufactured ImmunoCult-XF medium.
The Immunology Science Round Up
Antibiotic Binding Site Mutations – Researchers studied the rifampicin binding site of E. coli RNA polymerase.
CRISPR Screens for Cancer – Scientists combined genome-wide CRISPR screens in target cancer cells to identify pathways that regulate γδ T cell killing and BTN3A cell surface expression.
Tissue-Resident T Cell Metabolism – Researchers explored the metabolic adaptations supporting differentiation, survival, and function of tissue-resident memory CD8+ T cells.
Towards a Universal CAR T Cell Therapy for Blood Cancers – Epitope-edited CAR T cells were effective against patient-derived acute myeloid leukemia, B cell lymphoma, and acute T cell leukemia.
Image courtesy of Dr. Kristin Anderson
111 episodes
Fetch error
Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on October 30, 2024 01:18 ()
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 376802635 series 2895470
Guest:
Dr. Kristin Anderson is an Assistant Professor at the University of Virginia, where her lab focuses on engineering T cells to overcome immune suppression in the tumor microenvironment. She talks about how her cancer diagnosis changed her career focus, strategies for targeting ovarian cancer, and her transition from postdoc to professor.
Featured Products and Resources:
- Register now for IUIS 2023!
- Support the culture of human T cells and enhance your cell therapy development by using high-performance, cGMP-manufactured ImmunoCult-XF medium.
The Immunology Science Round Up
Antibiotic Binding Site Mutations – Researchers studied the rifampicin binding site of E. coli RNA polymerase.
CRISPR Screens for Cancer – Scientists combined genome-wide CRISPR screens in target cancer cells to identify pathways that regulate γδ T cell killing and BTN3A cell surface expression.
Tissue-Resident T Cell Metabolism – Researchers explored the metabolic adaptations supporting differentiation, survival, and function of tissue-resident memory CD8+ T cells.
Towards a Universal CAR T Cell Therapy for Blood Cancers – Epitope-edited CAR T cells were effective against patient-derived acute myeloid leukemia, B cell lymphoma, and acute T cell leukemia.
Image courtesy of Dr. Kristin Anderson
111 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.